Slide 1: Claritev Corporation Q2 2026 Results and Business Update
Claritev Corporation Q2 2026 Results and Business Update August 7, 2026 Confidential and Proprietary – Do not distribute without permission 1
Slide 2: Disclaimer
Disclaimer Forward-Looking Statements This presentation includes statements that express our management’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.”
Slide 3: Our purpose is simple
Our purpose is simple. We work to help make healthcare transparent and affordable for all. Confidential and Proprietary – Do not distribute without permission 3
Slide 4: The Vision
The Vision To Make Healthcare More Transparent and Affordable for All Patients Public Sector Providers Brokers | Employers Channel Partners Payers | TPA International Strategy & Insights Services PRODUCTS Claims Payment & Data & Network Intelligence Revenue Integrity Analytics Enterprise Data Platfo
Slide 5: Our Competitive Advantage
Our Competitive Network scale A multi-decade network footprint Advantage embedded across payers and providers Data & analytics $500M+ High provider acceptance Invested in 400k custom business rules derived Our solutions minimize provider from 750+ payers and 45+ years of R&D in 5 yrs abrasion and ac
Slide 6: Our Mission in Action
Our Mission in Action 750+ 60M Insurance carriers, plan admins Health Plan and other payer clients Members Served* >100K ~$180B Employers/Plan Claim Charges Sponsors Served* Processed For more than 45 years, Claritev has been delivering affordability, efficiency, 1.4M $25B Providers Potential Saving
Slide 7: Second Quarter 2026 Highlights
Second Quarter 2026 Highlights +6.6% +1.1% ~$30M Q2 2026 Results Exceeded Prior Year Revenue vs. PY Adjusted EBITDA vs. PY ACV Closed in Bookings 5 New Logos Recognized as a Leader in Key Highlights the Everest Group Pre- Payment Integrity Solutions PEAK Matrix Assessment TPA Expansion with ACE, Net
Slide 8: Results and Highlights
Results and Highlights $ in millions Quarter ended June 30 Six months Ended June 30 Q2 2026 Q2 2025 FY 2026 FY 2025 6.6% 6.2% $257.5 $502.2 $472.9 $241.6 Revenues 1.1% 2.2% (18.0%) $155.8 $302.7 $296.1 $154.0 Adjusted EBITDA1 Adjusted EBITDA Margin1 60.5% 63.8% 60.3% 62.6% 1 Adjusted EBITDA and Adju
Slide 9: Results and Highlights
Results and Highlights $ in millions Second Quarter 2026: Six Months ended June 30, 2026: 106.6% 106.2% Total Net Revenue Retention Rate1 Total Net Revenue Retention Rate1 $155.8M (60.5%) $302.7M (60.3%) Adjusted EBITDA2 Adjusted EBITDA2 $89.5M $126.2M Unlevered free cash flow2 Unlevered free cash f
Slide 10: Revenue by Service Line
Revenue by Service Line $ in millions Quarter ended June 30 Six months Ended June 30 Service Line 2026 2025 Change 2026 2025 Change Claims Intelligence $178.5 $157.0 13.7% $344.8 $310.4 11.1% Network $50.3 $54.1 (7.0)% $97.8 $101.0 (3.2)% Payment & Revenue $28.7 $30.5 (5.9)% $59.6 $61.5 (3.1)% Integ
Slide 11: Claritev PSAV Normalized Analysis - Rate/Volume/Mix
Claritev PSAV Normalized Analysis* - Rate/Volume/Mix PSAV Claim Volume (000’s) Rate/Vol/Mix ($M’s) - Revenue per Claim Analysis (Claims with Identified Savings) + $16 4,000 (+7.7%) +3% +11% $220 3,600 3,379 3,273 $22 3,129 3,148 $204 3,200 3,043 $(7) 2,800 FY25 Q2 FY25 Q3 FY25 Q4 FY26 Q1 FY26 Q2 Tot
Slide 12: Key Claims Volume/Pricing Trends
(Claims with Identified Savings) Key Claims Volume/Pricing Trends* Total Claims (with Savings) Charges Per Claim Potential Savings Per Claim Revenue Per Claim Q2 ‘26 Drivers 120% 117% 114% • Volume: Increase driven growth in NSA 110% 109% 110% claims 108% 108% 108% 109% • Savings: AI Initiatives 106
Slide 13: FY 2026 Guidance
FY 2026 Guidance FY 2026 Prior Guidance Revenue $1 billion to $1.02 billion $985 million to $1 billion Adjusted EBITDA1 $610 million to $620 million $605 million to $615 million Total Capital Spend2 $160 million to $170 million $160 million to $170 million Effective Tax Rate 24% to 28% 24% to 28% Fr
Slide 14: Strategic Investment Prioritization
Strategic Investment Prioritization Our primary uses of capital are to invest in our business, serve our clients, care for our associates, and maximize shareholder value. Organic investments to HIGHEST PRIORITY Guiding Principles fuel Vision 2030 Plan • Diversify & Accelerate HIGH PRIORITY Debt payd
Slide 15: Claritev has Been Re-Invigorated and is Positioned to Accelerate Growth
Claritev has Been Re-Invigorated and is Positioned to Accelerate Growth Essential Role in Healthcare Ecosystem 1 Growth opportunity to significantly expand TAM and accelerate growth in analytics with untapped international opportunity Operating Platform Built For Significant Scale 2 Ability to lever
Slide 16: Appendix
& claritev’ Appendix
Slide 17: Balance Sheet
Balance Sheet $ in millions DEBT STRUCTURE (Carrying Amounts, before debt discounts) 6/30/2026 Rate Maturity 2025 Revolving Credit Facility $ 70 SOFR+3.75% DEC-29 First-Out First Lien Term Loans 321 SOFR+3.75% DEC-30 Second-Out First Lien Term Loans 1,130 SOFR+4.60%+CSA1 DEC-30 Second-Out First Lien
Slide 18: Reconciliation of GAAP and Non-GAAP Items
Reconciliation of GAAP and Non-GAAP Items $ in thousands Three Months Ended Six Months Ended June 30, 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025 2026 2025 Net loss $ (59,226) $ (73,560) $ (80,570) $ (69,753) $ (62,640) $ (132,786) $ (133,959) Adjustments: Interest expense 100,253 99,542 99,4
Slide 19: Reconciliation of GAAP and Non-GAAP Items, continued
Reconciliation of GAAP and Non-GAAP Items, continued $ in thousands, except share and per share data Three Months Ended Six Months Ended June 30, 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025 2026 2025 Net loss $ (59,226) $ (73,560) $ (80,570) $ (69,753) $ (62,640) $ (132,786) $ (133,959) Adjus
Slide 20: Reconciliation of GAAP and Non-GAAP Items, continued
Reconciliation of GAAP and Non-GAAP Items, continued $ in thousands Three Months Ended Six Months Ended June 30, 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025 2026 2025 Net cash provided by (used in) operating activities $ 92,671 $ (45,779) $ 66,286 $ 19,857 $ 61,237 $ 46,892 $ 31,181 Purchases